Survival analysis also demonstrated that, similar to our published findings with GCH1, elevated expression of SPR or DHFR correlated with worse survival of glioma patients (Fig. 4c, Additional files 3 and 4). The gene discussed is DHFR; the disease is central nervous system cancer.